Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001415889-24-015363

Director acquired 4,660 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GOWEN MAXINE Director 2024-06-01 Option exercise +4,660 16,961 D
Derivatives
GOWEN MAXINE Director 2024-06-01 Option exercise · Restricted Stock Units −4,660 0 D
Loading xslF345X05/form4-06042024_040608.xml…